Contact Person : Customer Service; Last Date for the submission of abstract : 2nd March 2020; Description :Discover the Clinical and Commercial Potential of Gene Therapy and Editing Approaches Revolutionizing Hemophilia, Sickle Cell Disease and β-Thalassemia Treatment.